Aether THERAPEUTICS

Aether THERAPEUTICS

Early Stage

Breaking the Chains of Opioid Addiction

Breaking the Chains of Opioid Addiction

Overview

Raised this Round: Raised: $65,559

Total Commitments ($USD)

Platform

Netcapital

Start Date

08/21/2024

Close Date

12/06/2024

Min. Goal
$10,002
Max. Goal
$800,032
Min. Investment

$99

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$3.68

Pre-Money Valuation

$17,486,944

Year Founded

2017

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B2C

Margin

Low

Capital Intensity

High

Location

Austin, Texas

Business Type

Growth

Aether THERAPEUTICS, with a valuation of $17.5 million, is raising funds on NetCapital. The company is developing safe opioid pain therapy without the fear of addiction. Aether THERAPEUTICS’s low-dose ATX-001 is focused on breaking the chain of addiction while not blocking pain relief or causing withdrawal and other adverse effects. ATX-001 is a metabolite of naltrexone and has undergone pre-clinical testing on canines with no toxic effects. Wolfgang Sadee founded Aether THERAPEUTICS in December 2017. The current crowdfunding campaign has a minimum target of $10,002.24 and a maximum target of $800,032. The campaign proceeds will be used for animal testing, initial production of API, hiring, legal fees, and patents.

Summary Profit and Loss Statement

FY 2023 FY 2022

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$147,198

$-20,468

Summary Balance Sheet

FY 2023 FY 2022

Cash

$176,687

$16,530

Accounts Receivable

$0

$0

Total Assets

$182,422

$16,530

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Financials as of: 08/21/2024
Create a free account today to gain access to Kingscrowd analytics.

Raise History

Offering Name Close Date Platform Valuation Total Raised Security Type Status Reg Type
Aether THERAPEUTICS 12/06/2024 Netcapital $17,486,944 $65,559 Equity - Common Active RegCF

No prior online funding rounds.

Create a free account today to gain access to Kingscrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Aether THERAPEUTICS on NetCapital 2024
Platform: Netcapital
Security Type: Equity - Common
Valuation: $17,486,944
Price per Share: $3.68

Follow company

Follow Aether THERAPEUTICS on NetCapital 2024

Buy Aether THERAPEUTICS's Deal Report

Aether THERAPEUTICS Deal Report

Get Kingscrowd's comprehensive report on Aether THERAPEUTICS including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Aether THERAPEUTICS is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Aether THERAPEUTICS deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge